Concepedia

Yingqian Chen

YC

Statistics

Publications

6

Citations

475

H-Index

6

Active since

2018

Affiliations

Zhejiang University(Current)

Children's Hospital of Zhejiang University

Yingqian Chen is an author at Zhejiang University specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2018–2022

6

Publications

6

Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy

Xuejing Shao, Tianbai Zhong, Yue Wu et al. · Nature Chemical Biology · 2021 · 159 citations

, , +10

Ubiquitin-dependent degradation of CDK2 drives the therapeutic differentiation of AML by targeting PRDX2

Meidan Ying, Xuejing Shao, Hui Jing et al. · Blood · 2018 · 107 citations · Full text

, , +10

Inhibition of M2-like macrophages by all-trans retinoic acid prevents cancer initiation and stemness in osteosarcoma cells

Xuejing Shao, Senfeng Xiang, Yingqian Chen et al. · Acta Pharmacologica Sinica · 2019 · 99 citations · Full text

, , +14

Blockade of deubiquitinase YOD1 degrades oncogenic PML/RARα and eradicates acute promyelocytic leukemia cells

Xuejing Shao, Yingqian Chen, Wei Wang et al. · Acta Pharmaceutica Sinica B · 2021 · 63 citations · Full text

, , +12

Deneddylation of PML/RARα reconstructs functional PML nuclear bodies via orchestrating phase separation to eradicate APL

Xuejing Shao, Yingqian Chen, Aixiao Xu et al. · Cell Death and Differentiation · 2022 · 29 citations · Full text

, , +11

1–5 of 6